Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells

Nobuhiro Sakata, Thomas E. Phillips, Joseph L. Dixon

Journal of Lipid Research · 2001 · 18 citations · 50 references

DOIFull text

Open access

Concepts

Abstract

The transport of apolipoprotein B (apoB) between the endoplasmic reticulum (ER) and Golgi was studied in puromycin-synchronized HepG2 cells, using an antibody that could distinguish between apoB in ER and Golgi compartments. In cells with normal ER-to-Golgi transport, both albumin and apoB colocalized throughout the ER and appeared as intense, compact signals in Golgi. When ER-to-Golgi transport was blocked with brefeldin A, apoB and albumin remained colocalized in the ER network and three-dimensional constructed images showed more intense signals for both proteins in a central, perinuclear region of the ER. When protein synthesis was stopped in cells with brefeldin A-inhibited ER-to-Golgi transport, apoB degradation was visualized as a homogeneous decrease in fluorescence signal intensity throughout the ER that could be slowed with clasto-lactacystin β-lactone, a proteasome inhibitor. Incubation of cells with CP-10447, an inhibitor of microsomal triglyceride transfer protein, inhibited apoB, but not albumin, transport from ER to Golgi. Nanogold immunoelectron microscopy of digitonin-permeabilized cells showed proteasomes in close proximity to the cytosolic side of the ER membrane. Thus, newly synthesized apoB is localized throughout the entire ER and degraded homogeneously, most likely by neighboring proteasomes located on the cytosolic side of the ER membrane. Although albumin is colocalized with apoB in the ER, as expected, it was not targeted for ER-associated proteasomal degradation.—Sakata, N., T. E. Phillips, and J. L. Dixon. Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells. J. Lipid Res. 2001. 42: 1947–1958. The transport of apolipoprotein B (apoB) between the endoplasmic reticulum (ER) and Golgi was studied in puromycin-synchronized HepG2 cells, using an antibody that could distinguish between apoB in ER and Golgi compartments. In cells with normal ER-to-Golgi transport, both albumin and apoB colocalized throughout the ER and appeared as intense, compact signals in Golgi. When ER-to-Golgi transport was blocked with brefeldin A, apoB and albumin remained colocalized in the ER network and three-dimensional constructed images showed more intense signals for both proteins in a central, perinuclear region of the ER. When protein synthesis was stopped in cells with brefeldin A-inhibited ER-to-Golgi transport, apoB degradation was visualized as a homogeneous decrease in fluorescence signal intensity throughout the ER that could be slowed with clasto-lactacystin β-lactone, a proteasome inhibitor. Incubation of cells with CP-10447, an inhibitor of microsomal triglyceride transfer protein, inhibited apoB, but not albumin, transport from ER to Golgi. Nanogold immunoelectron microscopy of digitonin-permeabilized cells showed proteasomes in close proximity to the cytosolic side of the ER membrane. Thus, newly synthesized apoB is localized throughout the entire ER and degraded homogeneously, most likely by neighboring proteasomes located on the cytosolic side of the ER membrane. Although albumin is colocalized with apoB in the ER, as expected, it was not targeted for ER-associated proteasomal degradation. —Sakata, N., T. E. Phillips, and J. L. Dixon. Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells. J. Lipid Res. 2001. 42: 1947–1958. Apolipoprotein B-100 (apoB) is the structural protein for plasma VLDL and LDL and is synthesized primarily in hepatocytes (1Steinberg D. Carew T.E. Fielding C. Fogelman A.M. Mahley R.W. Sniderman A.D. Zilversmit D.B. Lipoproteins and the pathogenesis of atherosclerosis.Circulation. 1989; 80: 719-723Google Scholar, 2Davis R.A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver.Biochim. Biophys. Acta. 1999; 1440: 1-31Google Scholar). The secretion rate of apoB is an important factor determining the concentrations of apoB lipoproteins and cholesterol in blood (2Davis R.A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver.Biochim. Biophys. Acta. 1999; 1440: 1-31Google Scholar, 3Dixon J.L. Ginsberg H.N. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins—information obtained from cultured liver cells.J. Lipid Res. 1993; 34: 167-179Google Scholar). The rate of apoB secretion can vary during the course of the day within individuals (4Watts G.F. Moroz P. Barrett P.H. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies.Metabolism. 2000; 49: 1204-1210Google Scholar), and has been observed to be increased in patients with hyperlipidemias (5Ginsberg H.N. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.Diabetes Care. 1991; 14: 839-855Google Scholar). Studies to decipher the subcellular mechanisms regulating apoB and VLDL secretion have been performed largely in cultured cells. ApoB is synthesized on ribosomes attached to the endoplasmic reticulum (ER) and translocated through the ER membrane, and lipids are added to nascent apoB cotranslationally or posttranslationally [for a comprehensive review see Davis (2Davis R.A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver.Biochim. Biophys. Acta. 1999; 1440: 1-31Google Scholar)]. ApoB-lipoprotein particles are enlarged in subsequent lipidation steps, either in the ER (6Alexander C.A. Hamilton R.L. Havel R.J. Subcellular localization of B apoprotein of plasma lipoproteins in rat liver.J. Cell Biol. 1976; 69: 241-263Google Scholar) or in post-ER compartments (7Swift L.L. Valyi-Nagy K. Rowland C. Harris C. Assembly of very low density lipoproteins in mouse liver: evidence of heterogeneity of particle density in the Golgi apparatus.J. Lipid Res. 2001; 42: 218-224Google Scholar). Microsomal triglyceride transfer protein (MTP) is an ER lumenal protein that carries triglyceride and phospholipid to nascent apoB molecules (8Wetterau J.R. Aggerbeck L.P. Bouma M.E. Eisenberg C. Munck A. Hermier M. Schmitz J. Gay G. Rader D.J. Gregg R.E. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia.Science. 1992; 258: 999-1001Google Scholar, 9Jamil H. Dickson Jr., J.K. Chu C.H. Lago M.W. Rinehart J.K. Biller S.A. Gregg R.E. Wetterau J.R. Microsomal triglyceride transfer protein. Specificity of lipid binding and transport.J. Biol. Chem. 1995; 270: 6549-6554Google Scholar) and participates in early apoB-lipoprotein assembly (10Rustaeus S. Stillemark P. Lindberg K. Gordon D. Olofsson S-O. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells.J. Biol. Chem. Scholar). in the assembly of transport from ER to are apoB-lipoprotein particles observed in the ER (10Rustaeus S. Stillemark P. Lindberg K. Gordon D. Olofsson S-O. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells.J. Biol. Chem. Scholar), that transfer of lipids the apoB is to the plasma and it is of a VLDL particle that between and in that apoB secretion is or degradation J. S. Davis R.A. of apolipoprotein B the endoplasmic reticulum is blocked in a 1992; Scholar, J.L. Ginsberg H.N. and are but that secretion of apolipoprotein B in cells.J. Biol. Chem. 1993; Scholar, Davis R.A. In HepG2 cells, not the of the synthesized apolipoprotein Biol. Chem. 1995; 270: Scholar). ApoB is a for the cytosolic L. degradation of apolipoprotein Scholar, M. S. H. Ginsberg H.N. The degradation of apolipoprotein is by the and protein Biol. Chem. Scholar, T. degradation of apolipoprotein by the proteasome is by microsomal triglyceride transfer protein. on HepG2 cells with an inhibitor of microsomal triglyceride transfer Biol. Chem. Scholar, J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar). proteins that ER-associated degradation J.L. endoplasmic protein an to a Scholar, D. M. J. transfer of a protein from the endoplasmic reticulum to the proteasome for Scholar, T. reticulum protein of J. Scholar, M. K. of a protein from the endoplasmic reticulum to the for J. Scholar), apoB, located in the ER but with the ER J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar), and transport degradation by cytosolic or ER proteasomes J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar, M. Ginsberg H.N. of apolipoprotein for proteasomal degradation of a Biol. Chem. Scholar). important to the J. S. Davis R.A. of apolipoprotein B the endoplasmic reticulum is blocked in a 1992; Scholar, M. Ginsberg H.N. of apolipoprotein for proteasomal degradation of a Biol. Chem. Scholar, of apolipoprotein B can be by lipid Lipid Res. Scholar) for ER apoB degradation was with the that apoB to the and and is not nascent lipoprotein assembly H. Ginsberg H.N. of apoprotein B with the and during lipoprotein assembly or to the Biol. Chem. 2001; Scholar). apoB can be through the for degradation by the with the of cytosolic M. Ginsberg H.N. an translocated protein, is to the cytosolic protein Biol. Chem. 1995; 270: Scholar). are of apoB degradation in to proteasomal degradation. The of apoB degradation are in rat that apoB degradation largely in a post-ER in hepatocytes H. degradation of in rat 1993; Scholar, of apolipoprotein B in cultured rat hepatocytes in a reticulum Biol. Chem. 1995; 270: Scholar, M. of apolipoprotein B secretion an and with brefeldin and in of rat J. Scholar). has been that degradation of apoB with the LDL in the J. A. L. Barrett A.D. The of the LDL in apolipoprotein B 2000; Scholar). In the to apoB and albumin from the with and apoB transport between ER and Golgi was studied in cells, using an antibody that could distinguish between apoB in ER and Golgi. that apoB and albumin, proteins with throughout the ER normal transport and ER-to-Golgi transport is inhibited by brefeldin A. In to albumin, is in the apoB was degraded in the ER ER-to-Golgi transport was blocked with brefeldin A. are with the of apoB and the proteasome throughout the ER network J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar). and from was obtained from The and to apoB of G. albumin was from with or obtained from and brefeldin from CP-10447, was by M. D. of apolipoprotein B and triglyceride secretion in cells Lipid Res. Scholar). was obtained from and from of the HepG2 cells in with and on as J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar). that for In HepG2 cells with but for apoB and albumin, cells with for protein cells with and with for to and by using and was to protein transport between the ER and Golgi. inhibitor was to lipidation of In cells with and with with or or for to of protein synthesis and transport, and to of the to of cells with and for with with or of apoB transport of newly synthesized apoB and albumin was inhibited by brefeldin A. of with brefeldin A, was added to with brefeldin to of the apoB in ER by protein Cell and J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar, J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar). was to both plasma and and was to the plasma membrane. of cells with for cells with in for with and with in with for subsequent for cells performed in and of cells with for HepG2 cells with and for with in the cells with and with for and for or digitonin-permeabilized cells with and for with the or with or The on with and with an as in by J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar). low fluorescence was observed cells with and or of the of the was obtained to signals by cells with and apoB or albumin to be degraded or albumin, and proteasome signals from with the on a images constructed with on a for cytosolic apoB and albumin signals using intensity and of an entire and signals in the from intensity in was by the signal intensity by between in for cells with for and for in blocked by in in for binding was blocked with normal and in for with that been in the cells in a of or for to was with an for to to the in for with for with an and in to obtained in for degradation of apoB and of was plasma and and can be to apoB in the of HepG2 cells J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar). HepG2 cells with apoB and to the of signals throughout the ER and in a region that was as as it colocalized with signals from an antibody to a Golgi protein, ApoB signals with the throughout the ER, with observed in the region that with intense albumin have that apoB, with a of and with a ER protein J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar). The for apoB that with albumin and that the antibody for apoB in the Golgi. and are both that intense, albumin colocalized with and the intense albumin as a for Golgi in transport apoB and was to newly synthesized apoB transport in HepG2 cells. was to the of apoB and albumin from cells in of in signals for both apoB and albumin that a of apoB and albumin been from the cells, of secretion or degradation and of with a and cells of apoB and albumin synthesis was and cells in for apoB and albumin of and but could be throughout the ER with in the region and transport to the Golgi The with albumin with of and M. protein is in the endoplasmic reticulum transfer to the Golgi 1993; Scholar), observed transfer of albumin to Golgi in HepG2 cells The with apoB that apoB transfer to the Golgi is and the of signals for apoB and albumin to in cells that not been with that of is to largely cells of apoB and albumin, and of apoB and albumin synthesis and transport and of The transfer of apoB and albumin from ER to Golgi of protein synthesis of to the of apoB and albumin in the ER. a in cells with brefeldin for of to ER-to-Golgi transport of protein synthesis in not subsequent of protein ER-to-Golgi transport for apoB and albumin observed in the ER network of protein synthesis and to of apoB-lipoprotein assembly apoB transport and to is a protein that triglyceride and phospholipid from ER to apoB in the ER (8Wetterau J.R. Aggerbeck L.P. Bouma M.E. Eisenberg C. Munck A. Hermier M. Schmitz J. Gay G. Rader D.J. Gregg R.E. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia.Science. 1992; 258: 999-1001Google Scholar, 9Jamil H. Dickson Jr., J.K. Chu C.H. Lago M.W. Rinehart J.K. Biller S.A. Gregg R.E. Wetterau J.R. Microsomal triglyceride transfer protein. Specificity of lipid binding and transport.J. Biol. Chem. 1995; 270: 6549-6554Google Scholar). of and cells with CP-10447, an inhibitor of M. D. of apolipoprotein B and triglyceride secretion in cells Lipid Res. Scholar), apoB from the Golgi region in the of protein synthesis ApoB was localized throughout the ER, a to that of apoB in cells that with brefeldin A. synthesis and transport by that apoB transport from ER was lipid transfer was with In signals for apoB and albumin from of cells the of apoB and albumin more it was to through and the three-dimensional of apoB and albumin in the ER and Golgi. through transport and brefeldin cells apoB and albumin of protein images constructed and signal intensity was as of In a the three-dimensional that albumin was throughout the ER with a signal and in the Golgi in as in the When the of the was to from albumin signals observed in the ER in the Golgi was observed as a compact that the entire of the When ER-to-Golgi transport was with brefeldin signals for albumin not in Golgi but observed throughout the ER, that to the plasma membrane. In the in apoB was observed throughout the ER with a signal in the Golgi In brefeldin cells, apoB was in the ER to albumin, and was not in the Golgi. of the three-dimensional images of the brefeldin cells more signal from a that was increased signal intensity for both albumin and apoB in a of the ER the as The signals in the with the albumin, apoB, in cells with blocked ER-to-Golgi transport, apoB and albumin are synthesized and throughout the ER with increased signal intensity and that are to the plasma membrane. that apoB degradation was more in brefeldin HepG2 cells S. Ginsberg H.N. J.L. Studies of the of degradation of in cells.J. Biol. Chem. 1992; Scholar) and that apoB and the proteasome throughout the ER of the J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar). The to that degradation of apoB in the ER and not transport to a region in the ER or to a transport with brefeldin and in to of the ER apoB stopped apoB synthesis with of brefeldin apoB and albumin in the ER but not in the Golgi and observed in cells with protein synthesis of the ER or with increased apoB was added and of apoB signal intensity was observed to have throughout the ER In the the albumin signal was in the ER that albumin was not degraded J.L. S. Ginsberg H.N. secretion of apolipoprotein B-containing lipoproteins from cells by early degradation of apolipoprotein Biol. Chem. 1991; Scholar). of signal of the entire region of cells that of the apoB intensity was the albumin signal was during with but with in apoB observed of not of apoB and albumin signals in HepG2 cells. The apoB and albumin signals from the in by as in and of cells from The intensity from cells of was with that of cells as and the of apoB apoB degradation was inhibited in brefeldin cells, a proteasome clasto-lactacystin was added to the cells with brefeldin A. ER-to-Golgi transport was the apoB in the ER. proteasome inhibitor the intensity of apoB signal in the entire ER network was the intensity in cells with proteasome inhibitor The apoB signal in of the ER appeared in clasto-lactacystin cells, but a of the entire ER and not to a or a that of apoB signal and throughout the ER region in brefeldin and could be the proteasome was showed that in apoB colocalized with and of the proteasome J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar). was in the by for the of an proteasome When cells with ER with an antibody to and the antibody to apoB, was in the signals throughout the the signal for was and more the signal for The antibody was it can apoB in digitonin-permeabilized cells, as is located on the cytosolic side of the ER J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar). digitonin-permeabilized cells of cytosolic the signals for from proteasomes that are with on the cytosolic side of the ER. microscopy and to the of the proteasome more particles observed in close proximity to the ER digitonin-permeabilized cells with The more in particles to the ER or on the ER membrane. for the that the of proteasomal degradation is in to in the or on the cytosolic side of the ER apoB, is throughout the ER that the proteasomes that are most likely for degradation of newly synthesized apoB are located throughout the ER region in close proximity to apoB, but on the side the cytosolic of the ER is with the ER in HepG2 cells. HepG2 cells with and with as in and The cells with antibody by antibody with cells to an to particles enlarged by and and endoplasmic of In a J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar), observed apoB throughout the ER but could not distinguish between apoB in ER and Golgi compartments. In the it was to apoB transport between ER and Golgi by using the in apoB M. K. A. J. G. of apolipoprotein B Lipid Res. Scholar). antibody signals for apoB in the Golgi have J. J.L. of in apolipoprotein that are on the cytosolic side of the endoplasmic reticulum Cell Biol. Scholar), in apoB in in the Golgi. The for in apoB is located in the the as is to it not C. D. D. synthesis and transport of albumin and apolipoprotein B in cultured rat hepatocytes as studied by 34: Scholar) studied albumin and apoB synthesis and transport in the of rat using to protein In the of apoB and albumin synthesis and in the ER not early the of of the and the to the transport of albumin from ER to Golgi. using brefeldin A, and the visualized albumin and apoB in the ER in and with the to transport between compartments. When ER-to-Golgi transport was both apoB and albumin throughout the entire ER network and in the Golgi of protein of the signal of albumin and apoB in that of the albumin signal was in the Golgi with for apoB not The of albumin in Golgi that albumin from ER to Golgi most proteins M. proteins from endoplasmic reticulum to Golgi Biol. Chem. Scholar). the Golgi the entire in HepG2 cells, the that transport is to the Golgi to the plasma membrane. Although of apoB and albumin in the is that by microscopy of rat liver showed that albumin and apoB are not colocalized in Golgi S. L. of hepatic apolipoprotein in Golgi and Cell Biol. Scholar). albumin was throughout the Golgi apoB and to enlarged of in that enlarged VLDL particles a in the Golgi. When ER-to-Golgi transport was by the Golgi with brefeldin J. of Golgi proteins the ER in cells with brefeldin evidence for from Golgi to 1989; Scholar), both apoB and albumin in the ER. of the three-dimensional images of transport blocked cells that was a of more intense signal for both proteins in the of the ER. is not increased synthesis in or increased during The of and proteins within and between compartments of the are within not K. J. ER-to-Golgi transport visualized in Scholar, of protein in the of endoplasmic J. 1999; Scholar, T.E. of ER-to-Golgi transport in cells a of for and Scholar). is not apoB is in the ER or it is ER or lumenal The most from three-dimensional analysis of apoB and albumin in normal cells and in cells with blocked ER-to-Golgi transport is that with are both throughout the ER network and in the Golgi. is the that can distinguish between apoB in the ER and apoB in the Golgi compartments and of with that of ER-to-Golgi transport of both apoB and albumin was inhibited by brefeldin A, apoB transport was by CP-10447, an inhibitor of of the early transfer of triglyceride and phospholipid to apoB in the ER in the of the microsomal triglyceride transfer protein in apolipoprotein B lipoprotein Scholar). the in that apoB in the ER in cells, as that of apoB from a nascent lipoprotein and transport of nascent apoB lipoprotein particle or protein The of in apoB-lipoprotein assembly is of apoB the ER and to a nascent apoB particle (10Rustaeus S. Stillemark P. Lindberg K. Gordon D. Olofsson S-O. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells.J. Biol. Chem. Scholar). was to apoB through from the to proteins M. Ginsberg H.N. of of nascent apolipoprotein B the endoplasmic reticulum is with of the synthesis of apolipoprotein Biol. Chem. 2000; Scholar). that the and secretion of apoB a M. Ginsberg H.N. of of nascent apolipoprotein B the endoplasmic reticulum is with of the synthesis of apolipoprotein Biol. Chem. 2000; Scholar). In mouse hepatocytes M. C.H. J. Hamilton R.L. of the of microsomal triglyceride transfer protein in the liver of 1999; Scholar) could not particles in ER or Golgi. was a decrease in the secretion of in mouse that not for transport between ER and Golgi. Studies to that is important for the of a nascent apoB-lipoprotein particle in the ER. that the transport of apoB between ER and Golgi is is and that a lipoprotein particle is not be to the Golgi is with the that or low lipid apoB to to the and H. Ginsberg H.N. of apoprotein B with the and during lipoprotein assembly or to the Biol. Chem. 2001; Scholar). degradation of newly synthesized apoB has been observed in cells and in hepatocytes (2Davis R.A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver.Biochim. Biophys. Acta. 1999; 1440: 1-31Google Scholar, C. D. A. D. K. mechanisms regulating lipoprotein assembly and secretion in Lipid Res. 2000; Scholar) and is a for apoB secretion (2Davis R.A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver.Biochim. Biophys. Acta. 1999; 1440: 1-31Google Scholar, 3Dixon J.L. Ginsberg H.N. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins—information obtained from cultured liver cells.J. Lipid Res. 1993; 34: 167-179Google Scholar). in the of apoB degradation was in HepG2 cells ER-to-Golgi transport was blocked with brefeldin S. Ginsberg H.N. J.L. Studies of the of degradation of in cells.J. Biol. Chem. 1992; Scholar). of the with brefeldin degradation of apoB in the ER, in HepG2 cells likely the proteasome L. degradation of apolipoprotein Scholar, M. S. H. Ginsberg H.N. The degradation of apolipoprotein is by the and protein Biol. Chem. Scholar, T. degradation of apolipoprotein by the proteasome is by microsomal triglyceride transfer protein. on HepG2 cells with an inhibitor of microsomal triglyceride transfer Biol. Chem. Scholar, J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar, and that the binding of to apoB in the Biol. Chem. Scholar, J.L. degradation of apolipoprotein in Biophys. Acta. 1999; Scholar) and cytosolic J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar). and transport of apoB through the ER to degradation by proteasomes in the or on the cytosolic of the ER J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar, M. Ginsberg H.N. of apolipoprotein for proteasomal degradation of a Biol. Chem. Scholar). degradation of apoB is and as degraded of apoB are to in HepG2 cells S. Ginsberg H.N. J.L. Studies of the of degradation of in cells.J. Biol. Chem. 1992; Scholar). In the apoB degradation was to in cells and visualized by of apoB in the ER by a as observed in cells with proteasomal degradation D. D. A. J. K. Studies on mechanisms post-translational of apolipoprotein B and the of the Biol. Chem. 1999; Scholar). In the ER, apoB was to be with an K. J. A. M. D. Apolipoprotein B is with an in HepG2 cells.J. Biol. Chem. Scholar). In the an intense of apoB signal was not observed in ER or either not or in brefeldin cells, or in brefeldin cells with a proteasome inhibitor The and the that a of the of apoB nascent lipoprotein H. Ginsberg H.N. of apoprotein B with the and during lipoprotein assembly or to the Biol. Chem. 2001; Scholar), a proteasome degradation targeted for apoB is degraded by a proteasome located in close proximity to the by an apoB during apoB throughout the ER but to the H. Ginsberg H.N. of apoprotein B with the and during lipoprotein assembly or to the Biol. Chem. 2001; Scholar). lipidation and nascent particle not apoB is through the for degradation by a neighboring J.L. are for proteasome degradation of newly synthesized apolipoprotein B in HepG2 cells.J. Biol. Chem. 1999; Scholar), protein M. Ginsberg H.N. an translocated protein, is to the cytosolic protein Biol. Chem. 1995; 270: Scholar), are for degradation. is that apoB is and and from the and throughout the ER to secretion or transport Apolipoprotein B in the endoplasmic and the of lipoprotein 1999; Scholar). Studies of the of apoB in the ER not an and of apoB it is targeted for secretion or degradation Ginsberg H.N. The of apolipoprotein B not from the endoplasmic reticulum to the degradation of nascent apolipoprotein B the of the protein, apolipoprotein B is in Biol. Chem. 2000; Scholar). The not a in apoB is to a or for proteasomal as was for that in the with a proteasome inhibitor S. of proteasomal with the Cell Biol. 1999; Scholar, a to Cell Biol. Scholar). that ER-associated proteasomal degradation of apoB throughout the ER region and not to in of the apoB throughout the ER in cells with proteasome and ER-associated proteasomes are located throughout the ER and with apoB are with the proteasome degradation in was by to L. from the and of CP-10447, was by J. for apolipoprotein B-100 endoplasmic reticulum microsomal triglyceride transfer protein

References

50